The company said it completed the previously announced public offerings and issued 5 series of notes due 2027, 2028, 2030, 2032 and 2035. The offerings were made under Form S-3 registration statement (Reg. No. 333-269836) and completed on February 20, 2025.

1. 01

   The company said it completed the previously announced public offerings and issued 5 series of notes due 2027, 2028, 2030, 2032 and 2035. The offerings were made under Form S-3 registration statement (Reg. No. 333-269836) and completed on February 20, 2025.

2. 02

   Johnson & Johnson said it issued 4.500% Notes due 2027 in an aggregate principal amount of $750,000,000 and 4.550% Notes due 2028 in an aggregate principal amount of $750,000,000.

3. 03

   The company said it issued 4.700% Notes due 2030 in an aggregate principal amount of $1,000,000,000, and 4.850% Notes due 2032 and 5.000% Notes due 2035 in aggregate principal amounts of $1,250,000,000 each.

4. 04

   The company said it entered into an underwriting agreement on February 18, 2025 with Citigroup Global Markets Inc., BofA Securities, Inc. and J.P. Morgan Securities LLC as representatives of the underwriters, under which it agreed to issue and sell the notes to the underwriters.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.